BioSpace News Archive

Electromed, Inc. announced financial results for the three months ended December 31, 2018 (Q2 FY 2019).

In the news release, “Liberty Health Sciences Announces Independent Findings in Response to Short Seller Allegations and Further Strategic Changes”, issued Feb. 12, 2019 by Liberty Health Sciences Inc.

IQPC is pleased to announce the new Keynote speaker for the 17th Cold Chain Global Forum Canada!

Feinstein Institute for Medical Research President and CEO Kevin J. Tracey, MD has joined with leading scientists across Canada, Europe and Asia, to discover the critical role the chemical acetylcholine plays as a neurotransmitter in combating chronic viral infection, as published online today in Science.

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2018 on Thursday, February 28, 2019, following the close of the market.

Innovative Therapies Will Require Innovations in Financing and Regulations

New molecular assay, PlexPCR RespiVirus, submitted to TGA for clinical approval

Ascletis Pharma Inc. and 3-V Biosciences, Inc. jointly announce that Ascletis, through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Biosciences’ FASN inhibitor TVB-2640, a first-in-class, Phase 2-ready drug candidate for non-alcoholic steatohepatitis, in Greater China.

Intercare Holdings Insurance Services, a privately held national third-party administrator, welcomes Amy Evans to its Liability Division.

Veeva Systems (NYSE:VEEV) today announced increasing numbers of life sciences companies are adopting applications in Veeva Vault RIM, the first unified suite of RIM applications on one cloud platform, to modernize their regulatory processes and systems.